Notice of Intent to Sole Source – PMT
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Clinical Center (CC), Department of Perioperative Medicine (DPM) has issued a Notice of Intent to Sole Source for the procurement of electrodes and accessories for Neuro Surgery from PMT Corp. This action is based on the determination that PMT is the sole manufacturer with proprietary specifications. Responses from interested parties are due by February 13, 2026, at 9am EST.
Scope of Requirement
The NIH Clinical Center requires specific electrodes and accessories for Neuro Surgery to support Dr. Zaghloul's protocol. These PMT electrodes have been used in the operating room for several years, are compatible with existing equipment, and are critical for ensuring optimal surgical outcomes for patients under the protocol. The product service code is 6515 (Medical Instruments, Equipment, and Supplies) and the NAICS code is 339112 (Surgical and Medical Instrument Manufacturing). The place of performance is Bethesda, MD 20892 USA.
Contract & Timeline
- Type: Notice of Intent to Sole Source for a firm fixed-price purchase order.
- Set-Aside: None (sole source action).
- Response Due: February 13, 2026, 9am EST.
- Published: January 23, 2026.
Justification for Sole Source
The proposed vendor, PMT Corp, located at 1500 Park Rd, Chanhassen, MN 55317, is identified as the sole manufacturer of the required electrodes, which possess proprietary specifications. Their products are essential for compatibility with current equipment and have been integral to Dr. Zaghloul's protocol, contributing to successful surgical outcomes. The acquisition is being conducted under FAR Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), which allows for solicitation from a single source when only one is reasonably available for purchases not exceeding the simplified acquisition threshold. Contracts under FAR Part 13 are exempt from FAR Part 6 competition requirements.
Response Instructions
This is a notice of intent, not a request for quotation. A solicitation document will not be issued. Interested parties who believe they can meet this requirement may identify their interest and capabilities by submitting comments to Kristin Nagashima, Contract Specialist, at Kristin.nagashima@nih.gov by the specified closing date. The government's determination not to compete this requirement based upon responses to this notice is solely at its discretion.